Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 115 citing Taylor: Cholesterol reduction and life expectancy: a model incorporating multiple risk factors. (0.09 sec) 

The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, …


NM Kaplan - Archives of Internal Medicine, 1989 - archinte.highwire.org
\s=b\The contribution of obesity to cardiovascular risk has not been adequately appreciated because
of a failure to recognize the involvement of upper-body predominance of body weight with
hypertension, diabetes, and hypertriglyceridemia even in the absence of significant ...
Cited by 1215 - Related articles - All 4 versions

Lowering cholesterol concentrations and mortality: a quantitative review of primary …

- nih.gov [PDF] 
MF Muldoon, SB Manuck, KA Matthews - British Medical Journal, 1990 - bmj.com
Abstract Objective-To determine the effects of lowering cholesterolconcentrationsontotalandcausespecific
mortality in randomised primary prevention trials. Design-Qualitative (meta-analytic) evaluation
of total mortality from coronary heart disease, cancer, and causes not related to illness in ...
Cited by 673 - Related articles - All 8 versions

The cost-effectiveness of counseling smokers to quit


SR Cummings, SM Rubin, G Oster - Jama, 1989 - Am Med Assoc
Cigarette smoking is the most important preventable cause of death in the United States. Surveys
of patients, however, suggest that many physicians do not routinely counsel smokers to quit.
Because physicians may not consider counseling against smoking to be as worthwhile as ...
Cited by 270 - Related articles - All 3 versions

Improving health: measuring effects of medical care

- ubc.ca [PDF] 
JP Bunker, HS Frazier, F Mosteller - The Milbank Quarterly, 1994 - jstor.org
JOHN P. BUNKER, HOWARD S. FRAZIER, and FREDERICK MOSTELLER ... XW TITHIN THIS
CENTURY, AVERAGE LIFE EXPECTANCY has increased from approximately 45 to 75 years
for citizens ... (Hadley 1982). Today most observers would agree that the causes of
Cited by 212 - Related articles - BL Direct - All 6 versions

Cost and health implications of cholesterol lowering


L Goldman, DJ Gordon, BM Rifkind, SB Hulley, AS … - Circulation, 1992 - pt.wkhealth.com
Background. A broad, scientific consensus supports the role of cholesterol as a risk factor for
coronary heart disease and agrees that lowering cholesterol levels will reduce coronary heart
disease incidence. Cost-effectiveness analysis is a potentially powerful method for ...
Cited by 194 - Related articles - All 4 versions

Communicating the benefits of chronic preventive therapy: does the format of …


JE Hux, CD Naylor - Medical Decision Making, 1995 - mdm.sagepub.com
JANET E. HUX, MSc, MD, C. DAVID NAYLOR, MD, DPhil ... Patients' informed acceptance of
chronic medical therapy hinges on communicating the ... Advised of a relative risk
reduction-"34% reduction in heart attacks"-88% of the patients ... The authors conclude ...
Cited by 158 - Related articles - BL Direct - All 2 versions

Risk behaviors and health: Contrasting individual and population perspectives

- tamu.edu [PDF] 
RW Jeffery - American Psychologist, 1989 - psycnet.apa.org
This article discusses risk behaviors, seemingly voluntary actions of individuals that have adverse
health consequences. The central theme is to examine these behaviors from two contrasting
perspectives, that of the individual and that of the population as a whole. It is argued that ...
Cited by 134 - Related articles - All 6 versions

Cutting into cholesterol. Cost-effective alternatives for treating …


BP Kinosian, JM Eisenberg - JAMA, 1988 - Am Med Assoc
We performed an analysis of the cost-effectiveness of treating individuals with significantly elevated
levels of total serum cholesterol (greater than 6.85 mmol/L [greater than 265 mg/dL], comparing
treatment with three alternative agents: cholestyramine resin, colestipol, and oat bran (a ...
Cited by 134 - Related articles - All 3 versions

How can we best prolong life? Benefits of coronary risk factor reduction in non- …

- bmj.com [PDF] 
JS Yudkin - British medical journal, 1993 - bmj.com
Abstract Objective-To compare the theoretical benefits of different approaches to reduce risk
factors for coronary heart disease in subjects at risk. Design-The results of findings from
meta- analyses of intervention studies on cause specific mortality and of observational ...
Cited by 132 - Related articles - BL Direct - All 5 versions

Clinical guideline, part 2: cholesterol screening in asymptomatic adults, revisited


AM Garber, WS Browner, SB Hulley - Annals of internal medicine, 1996 - Am Coll Physicians
Design: Pooled analysis of clinical trials, supplemented by analysis of data from the Framingham
Heart Study, to estimate the effect of cholesterol reduction in patient groups stratified by cardiac
risk. ... Study Selection: Published randomized controlled trials of cholesterol reduction, ...
Cited by 119 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google